|Videos|May 15, 2019
Tau Deposition Patterns in Retired NFL Football Players
Author(s)Bobby Lazzara, MD
How are you counseling patients and families about the risks and benefits of playing sports with repetitive head blows and the risk of CTE?
Advertisement
A prospective study compared 26 former NFL players with cognitive and neuropsychiatric symptoms with 31 controls looking at tau deposition with positron emission tomography.1
Why? Because the neuropatholical diagnosis of chronic traumatic encephalopathy (CTE) from repetitive head impacts is based on a specific pattern of tau deposition with minimal amyloid deposition, which distinguishes it from other disorders like Alzheimer disease.
Findings
Tau deposition was higher in former players compared with controls in three regions:
• Bilateral superior frontal
• Bilateral medial temporal
• And left parietal
Participants did not have elevated amyloid beta levels and there was no association between tau and scores on cognitive or neuropsychiatric tests.
The study is a small cohort and more research is needed, but how are you counseling patients and families about the risks and benefits of playing sports with repetitive head blows and the risk of CTE?
Reference
1. Stern RA, Adler CH, Chen K, et al. Tau Positron-Emission Tomography in Former National Football League Players . N Engl J Med. 2019;380):1716-1725.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update
September 15th 2025
- 2025 Women in Neurology Conference: Educating, Mentoring, and Networking
September 15th 2025
- This Week on NeurologyLive® — September 15, 2025
September 15th 2025
- NeurologyLive® Brain Games: September 14, 2025
September 14th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
MDA and PPMD Release Consensus Guidelines for Safe and Equitable Use of Gene Therapy in Duchenne
2
Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update
3
10 Years of the Women Neurologists Group: A Preview of the 4th Annual Conference
4
This Week on NeurologyLive® — September 15, 2025
5